News

Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
Moderna Falls on Fears New CDC Vaccine Advisory Panel Could Cloud RSV Shot Prospects
The panel meeting for Moderna's RSV shot, scheduled for later this month, will be the "first time for investors to see the ...
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Independent Journal Review20h
Biden Admin Spent Weeks ‘Downplaying’ COVID Vaccine Risks Before Issuing Formal Warning, Senate Report Alleges
Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated with the ...
DelveInsight Business Research, LLP: Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight
According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease mechanisms have yielded new diagnostic ...